Advertisement

Dose-Dependent Absorption Profile of Different Magnesium Compounds

  • Mehmet Ates
  • Servet Kizildag
  • Oguz Yuksel
  • Ferda Hosgorler
  • Zeynep Yuce
  • Guven Guvendi
  • Sevim Kandis
  • Aslı Karakilic
  • Basar Koc
  • Nazan UysalEmail author
Article

Abstract

Magnesium, one of the basic elements for the human body, is necessary for many physiological functions. Magnesium deficiency is widely observed as a result of the reduced nutrient content of foods, over-cooking, diseases, drugs, alcohol, and caffeine consumption. Taking a dietary supplement is necessary magnesium deficiency. It has been demonstrated that absorption of organic magnesium compounds is better than absorption of inorganic compounds. The aim of this study is to investigate transitions to tissues of different organic magnesium compounds in different doses and whether there is a difference in the organic acid–bounded compounds (magnesium citrate and magnesium malate) and the amino acid–bounded compounds (magnesium acetyl taurate and magnesium glycinate), associated with transition and bioavailability. In addition, the effects of split dosages of high doses in a high volume of solvent on tissue magnesium levels are being investigated, because galenic formulation problems are regarded to prepare convenient dosage that can be taken once a day. All magnesium compounds were administered as three different doses, 45, 135, and 405 mg/70 kg elemental magnesium, were given per orally to Balbc mice. In a second set of experiments, 405 mg/70 kg high dose was divided into two doses of 202.5 mg/70 kg each and administered every 12 h. Brain, muscle tissues, and serum magnesium levels measured in all experimental groups and control 24 h later. Brain magnesium levels were found increased in all magnesium acetyl taurate administered subjects. Magnesium citrate increased muscle and brain magnesium levels in a dose-independent manner. We showed that dividing high doses of daily administered magnesium compounds did not sufficiently increase tissue magnesium levels. Although passive paracellular mechanism by solvent drag is the main mechanism of Mg absorption, other factors (electrochemical gradient effects, transcellular transporter mechanisms, magnesium status) should be effective on our results. It is necessary for further research on long-term administration of different magnesium compounds and their effect on other tissues.

Keywords

Magnesium acetyl taurate Magnesium malate Magnesium citrate Magnesium glycinate Brain Muscle Divided dose 

Notes

Compliance with Ethical Standards

The experiments was carried out according to the Guiding Principles in the Use of Experimental Animals and approved by the Animal Care and Use Committee of the Dokuz Eylul University, School of Medicine.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Jiafu SZGYY (1995) Effect of organic manure on qualities of crops. Plant Nutrition and Fertilizing Science 2:007Google Scholar
  2. 2.
    DiNicolantonio JJ, O’Keefe JH (2018) Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart 5(1):e000668.  https://doi.org/10.1136/openhrt-2017-000668 CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Swaminathan R (2003) Magnesium metabolism and its disorders. Clin Biochem Rev 24(2):47–66PubMedCentralGoogle Scholar
  4. 4.
    Naithani M, Bharadwaj J, Darbari A (2014) Magnesium: the fifth electrolyte. Journal of Medical Nutrition and Nutraceuticals 3(2):66Google Scholar
  5. 5.
    Noronha JL, Matuschak GM (2002) Magnesium in critical illness: metabolism, assessment, and treatment. Intensive Care Med 28(6):667–679.  https://doi.org/10.1007/s00134-002-1281-y CrossRefGoogle Scholar
  6. 6.
    de Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95(1):1–46.  https://doi.org/10.1152/physrev.00012.2014 CrossRefGoogle Scholar
  7. 7.
    Schuchardt JP, Hahn A (2017) Intestinal absorption and factors influencing bioavailability of magnesium—an update. Curr Nutr Food Sci 13(4):260–278.  https://doi.org/10.2174/1573401313666170427162740 CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Uysal N, Kizildag S, Yuce Z, Guvendi G, Kandis S, Koc B, Karakilic A, Camsari UM, Ates M (2018) Timeline (bioavailability) of magnesium compounds in hours: which magnesium compound works best? Biol Trace Elem Res 187:128–136.  https://doi.org/10.1007/s12011-018-1351-9 CrossRefGoogle Scholar
  9. 9.
    Coudray C, Rambeau M, Feillet-Coudray C, Gueux E, Tressol JC, Mazur A, Rayssiguier Y (2005) Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res 18(4):215–223Google Scholar
  10. 10.
    Fine KD, Santa Ana CA, Porter JL, Fordtran JS (1991) Intestinal absorption of magnesium from food and supplements. J Clin Invest 88(2):396–402.  https://doi.org/10.1172/jci115317 CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Karagulle O, Kleczka T, Vidal C, Candir F, Gundermann G, Kulpmann WR, Gehrke A, Gutenbrunner C (2006) Magnesium absorption from mineral waters of different magnesium content in healthy subjects. Forsch Komplementarmed 13(1):9–14.  https://doi.org/10.1159/000090016 Google Scholar
  12. 12.
    Musso CG (2009) Magnesium metabolism in health and disease. Int Urol Nephrol 41(2):357–362CrossRefGoogle Scholar
  13. 13.
    Nishizawa Y, Morii H, Durlach J (2007) New perspectives in magnesium research. Springer, BerlinCrossRefGoogle Scholar
  14. 14.
    Jahnen-Dechent W, Ketteler M (2012) Magnesium basics. Clin Kidney J 5(Suppl 1):i3–i14.  https://doi.org/10.1093/ndtplus/sfr163 CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Ranade VV, Somberg JC (2001) Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther 8(5):345–357CrossRefGoogle Scholar
  16. 16.
    Hartle JW, Morgan S, Poulsen T (2016) Development of a model for in-vitro comparative absorption of magnesium from five magnesium sources commonly used as dietary supplements. FASEB J 30(1_supplement):128.126Google Scholar
  17. 17.
    Razak MA, Begum PS, Viswanath B, Rajagopal S (2017) Multifarious beneficial effect of nonessential amino acid, glycine: a review. Oxidative Med Cell Longev 2017:1–8Google Scholar
  18. 18.
    Zhong Z, Wheeler MD, Li X, Froh M, Schemmer P, Yin M, Bunzendaul H, Bradford B, Lemasters JJ (2003) L-glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr & Metab Care 6(2):229–240CrossRefGoogle Scholar
  19. 19.
    Larson MD (1983) Glycine and the blood-brain barrier. Anesthesiology 58(5):488–489CrossRefGoogle Scholar
  20. 20.
    Kang YS, Ohtsuki S, Takanaga H, Tomi M, Hosoya K, Terasaki T (2002) Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity. J Neurochem 83(5):1188–1195CrossRefGoogle Scholar
  21. 21.
    Kang YS (2000) Taurine transport mechanism through the blood-brain barrier in spontaneously hypertensive rats. Adv Exp Med Biol 483:321–324CrossRefGoogle Scholar
  22. 22.
    Kong WX, Chen SW, Li YL, Zhang YJ, Wang R, Min L, Mi X (2006) Effects of taurine on rat behaviors in three anxiety models. Pharmacol Biochem Behav 83(2):271–276.  https://doi.org/10.1016/j.pbb.2006.02.007 CrossRefGoogle Scholar
  23. 23.
    Tamai I, Senmaru M, Terasaki T, Tsuji A (1995) Na(+)- and Cl(-)-dependent transport of taurine at the blood-brain barrier. Biochem Pharmacol 50(11):1783–1793CrossRefGoogle Scholar
  24. 24.
    Tsuji A, Tamai I (1996) Sodium- and chloride-dependent transport of taurine at the blood-brain barrier. Adv Exp Med Biol 403:385–391CrossRefGoogle Scholar
  25. 25.
    Konishi M (2005) Cell membrane transport of magnesium. Clin calcium 15(2):233–238Google Scholar
  26. 26.
    Beyenbach KW (1990) Transport of magnesium across biological membranes. Magnes Trace Elem 9(5):233–254Google Scholar
  27. 27.
    Gnoni GV, Priore P, Geelen MJ, Siculella L (2009) The mitochondrial citrate carrier: metabolic role and regulation of its activity and expression. IUBMB Life 61(10):987–994.  https://doi.org/10.1002/iub.249 CrossRefGoogle Scholar
  28. 28.
    Bhutia YD, Kopel JJ, Lawrence JJ, Neugebauer V, Ganapathy V (2017) Plasma membrane Na(+)-coupled citrate transporter (SLC13A5) and neonatal epileptic encephalopathy. Molecules 22(3).  https://doi.org/10.3390/molecules22030378
  29. 29.
    Chiu HY, Yeh TH, Huang YC, Chen PY (2016) Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials. Pain Physician 19(1):E97–E112Google Scholar
  30. 30.
    Dahle LO, Berg G, Hammar M, Hurtig M, Larsson L (1995) The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol 173(1):175–180CrossRefGoogle Scholar
  31. 31.
    Roffe C, Sills S, Crome P, Jones P (2002) Randomised, cross-over, placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps. Med Sci Monit 8(5):Cr326–Cr330Google Scholar
  32. 32.
    Garrison SR, Allan GM, Sekhon RK, Musini VM, Khan KM (2012) Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev (9):Cd009402.  https://doi.org/10.1002/14651858.CD009402.pub2
  33. 33.
    Nygaard IH, Valbo A, Pethick SV, Bohmer T (2008) Does oral magnesium substitution relieve pregnancy-induced leg cramps? Eur J Obstet Gynecol Reprod Biol 141(1):23–26.  https://doi.org/10.1016/j.ejogrb.2008.07.005 CrossRefGoogle Scholar
  34. 34.
    Zhou K, West HM, Zhang J, Xu L, Li W (2015) Interventions for leg cramps in pregnancy. Cochrane Database Syst Rev (8):Cd010655.  https://doi.org/10.1002/14651858.CD010655.pub2
  35. 35.
    Dai Z, Zhou H, Zhang S, Gu H, Yang Q, Zhang W, Dong W, Ma J, Fang Y, Jiang M, Xin F (2018) Current advance in biological production of malic acid using wild type and metabolic engineered strains. Bioresour Technol 258:345–353.  https://doi.org/10.1016/j.biortech.2018.03.001 CrossRefGoogle Scholar
  36. 36.
    Huypens P, Pillai R, Sheinin T, Schaefer S, Huang M, Odegaard ML, Ronnebaum SM, Wettig SD, Joseph JW (2011) The dicarboxylate carrier plays a role in mitochondrial malate transport and in the regulation of glucose-stimulated insulin secretion from rat pancreatic beta cells. Diabetologia 54(1):135–145.  https://doi.org/10.1007/s00125-010-1923-5 CrossRefGoogle Scholar
  37. 37.
    Verhas M, de la Gueronniere V, Grognet JM, Paternot J, Hermanne A, Van den Winkel P, Gheldof R, Martin P, Fantino M, Rayssiguier Y (2002) Magnesium bioavailability from mineral water. A study in adult men. Eur J Clin Nutr 56(5):442–447.  https://doi.org/10.1038/sj.ejcn.1601333 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.College of Vocational School of Health Services, School of MedicineDokuz Eylul UniversityIzmirTurkey
  2. 2.Department of Sports Medicine, School of MedicineDokuz Eylul UniversityIzmirTurkey
  3. 3.Department of Physiology, School of MedicineDokuz Eylul UniversityIzmirTurkey
  4. 4.Department of Medical Biology and Genetics, School of MedicineDokuz Eylul UniversityIzmirTurkey

Personalised recommendations